YBGJ Yubo International Biotech Ltd
Electromedical & Electrotherapeutic Apparatus · OTC · SEC CIK 895464 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY68,727.8%
TTM net income YoY31.6%
TTM EPS YoY100.0%
Revenue 3-yr CAGR-73.4%
Net income 3-yr CAGR—
Margins
Gross margin66.1%
Operating margin-8,232.7%
Net margin-7,171.5%
FCF margin—
EBITDA margin-7,667.1%
Returns
ROE—
ROA-110.4%
ROIC (approx.)—
Asset turnover0.02x
Leverage & solvency
Liabilities / assets544.9%
Debt / equity—
Current ratio0.16x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.47x
Accruals ratio-58.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $12,353 | $3,470 |
| Cost of revenue | $4,188 | $822 |
| Gross profit | $8,165 | $2,648 |
| Operating income | -$1.19M | -$1.77M |
| Pretax income | -$1.19M | -$1.98M |
| Income tax | $0 | $0 |
| Net income | -$1.08M | -$1.78M |
| EBITDA | -$1.02M | -$1.60M |
| EPS (diluted) | -0.01 | -0.02 |
| Weighted avg. shares (diluted) | 139.64M | 119.82M |
| Banking | ||
| Net interest income | — | $50 |
| Deposits | $71,135 | $68,500 |
| Balance sheet | ||
| Cash & equivalents | $8,062 | $7,015 |
| Receivables | $138,043 | $164,984 |
| Inventory | $24,034 | $36,953 |
| Current assets | $667,512 | $682,751 |
| PP&E, net | $43,030 | $205,911 |
| Intangibles | $42,080 | $50,523 |
| Total assets | $847,094 | $1.53M |
| Current liabilities | $2.79M | $4.72M |
| Total liabilities | $2.79M | $4.83M |
| Shareholders' equity | -$1.95M | -$3.42M |
| Cash flow statement | ||
| Operating cash flow | -$842,802 | -$1.34M |
| Investing cash flow | $0 | $118,431 |
| Financing cash flow | $849,545 | $1.41M |
| Depreciation & amortization | $167,581 | $169,875 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.